Stallergenes will use Magic's solution to integrate its various purchasing systems with its SAP ERP.
Magic Software Enterprises Ltd. (Nasdaq: MGIC; TASE: MGIC) has sold its iBOLT integration platform to European biopharmaceutical company Stallergenes SA (Euronext: GENP), a developer of severe allergic respiratory illnesses. Magic did not disclose the size of the deal
Stallergenes will use Magic's solution to integrate its various purchasing systems with its SAP ERP. In 2005, the company used the iBOLT solution to build an online prescription tracking service. Published by Globes [online], Israel business news - www.globes-online.com - on January 17, 2012 © Copyright of Globes Publisher Itonut (1983) Ltd. 2012